User banner image
User avatar
  • admin

Posts

Amcor to report fiscal 2025 third quarter results

ZURICH, April 26, 2025 /PRNewswire/ — Amcor plc (“Amcor”) (NYSE: AMCR, ASX: AMC) will announce its fiscal 2025 third quarter results for the three month...

MDJM LTD Announces Receipt of Nasdaq Delisting Determination and Plan to Request a Hearing before the Nasdaq Hearings Panel

LETHAM, Scotland, April 26, 2025 /PRNewswire/ — MDJM LTD (Nasdaq: UOKA) (the “Company” or “MDJM”), an integrated global culture-driven asset management company, today announced that...

Webull Files Annual Report on Form 20-F for Year Ended December 31, 2024

ST. PETERSBURG, Fla., April 26, 2025 /PRNewswire/ — Webull Corporation (NASDAQ: BULL) today announced the filing of its annual report on Form 20-F for the...

U.S. Small Local Grocers Market 2025-2029: Navigating Rising Costs and Shrinking Margins – State and Local Communities Find Creative Solutions to Retain Small Local Grocers

Dublin, April 25, 2025 (GLOBE NEWSWIRE) — The “Small Local Grocers in the US” report has been added to ResearchAndMarkets.com’s offering. Despite maintaining marginal current...

Cellulite Treatment Market Trends, Growth Opportunities and Shares 2025-2030; Featuring Key Players – Hologic (Cynosure), Merz Pharma, Syneron Medical, Zimmer Aesthetics & More

Dublin, April 25, 2025 (GLOBE NEWSWIRE) — The “Cellulite Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” report has been added...

Okita Nail Fungus Light Under Review: Best At-Home Toenail Fungus Cleaning Light for Onychomycosis

Discover How the Okita Nail Fungus Light Uses Red & Blue LED Therapy to Help Improve Nail Clarity at Home—A Drug-Free, Pain-Free Solution for Onychomycosis...

Codetta Bio Launches Concerto™ System at AACR 2025 and Invites Attendees to Be a Part of “The Opening Concerto”

Experience the harmony of multi-omics with Codetta Bio’s groundbreaking Concerto™ System—and be among the first to play a leading role in its debut DURHAM, N.C.,...

VYNE Therapeutics Provides Update on VYN202 Program

BRIDGEWATER, N.J., April 25, 2025 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that the U.S. Food and Drug...

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted...

Allarity Therapeutics Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025

TARPON SPRINGS, Fla., April 25, 2025 — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing...